TY - JOUR
T1 - Proceedings of the second annual dengue endgame summit
T2 - A call to action
AU - Hardy, Céline S.C.
AU - Bahr, Lauren E.
AU - Rothman, Alan L.
AU - Anderson, Kathryn B.
AU - Barba-Spaeth, Giovanna
AU - Weiskopf, Daniela
AU - Ooi, Eng Eong
AU - Marques, Ernesto T.A.
AU - Bonsignori, Mattia
AU - Barrett, Alan D.T.
AU - Kirkpatrick, Beth D.
AU - Castanha, Priscila M.S.
AU - Hamins-Puertolas, Marco
AU - Christofferson, Rebecca C.
AU - Dimopoulos, George
AU - Oliveira, Fabiano
AU - Chiang, Lillian W.
AU - Ko, Albert I.
AU - Gunale, Bhagwat
AU - Kulkarni, Prasad
AU - Perkins, T. Alex
AU - Dorigatti, Ilaria
AU - Stewart, Telisa
AU - Shaw, Jana
AU - Johansson, Michael A.
AU - Thomas, Stephen J.
AU - Waickman, Adam T.
N1 - Publisher Copyright:
© 2025 Barclay-Korboi et al.
PY - 2025/4
Y1 - 2025/4
N2 - On August 7–9, 2024, the second annual dengue “endgame” summit was held in Syracuse, NY, hosted by the Global Health Institute at SUNY Upstate Medical Uni-versity. The meeting brought together attendees from around the world, with talks spanning healthcare, government control programs, basic research, and medical countermeasure development efforts. The summit goal was to work toward a better understanding of what dengue control could look like and the steps required to reach such a goal. The objectives of the meeting were to discuss the current global state of dengue, what dengue “control” might look like, and to discuss actionable pathways for achieving dengue control. Topics covered throughout the meeting included DENV immunity and pathogenesis, challenges in countermeasure development, innovative vector control strategies, dengue diagnostics, addressing challenges in science communication, and vaccine hesitancy. Several fundamental knowledge gaps were repeatedly highlighted by the summit attendees and were cited as critical barriers to the development, deployment, and evaluation of effective dengue countermeasures. These gaps include (1) the lack of a broadly applicable immunologic biomarker/ correlate of DENV immunity and (2) the lack of universally accepted/applicable metrics for quantifying dengue severity in the setting of countermeasure evaluations. In addition, the lack of clear and consistent international leadership in the global dengue control effort was cited as a barrier to widespread and synergistic research and countermeasure development/deployment activities. Despite these persistent roadblocks, summit attendees expressed optimism that holistic and multi-tiered approaches—incorporating optimal use of existing and nascent countermeasure technologies deployed in collaboration with local communities—could be effective in progressing toward dengue control.
AB - On August 7–9, 2024, the second annual dengue “endgame” summit was held in Syracuse, NY, hosted by the Global Health Institute at SUNY Upstate Medical Uni-versity. The meeting brought together attendees from around the world, with talks spanning healthcare, government control programs, basic research, and medical countermeasure development efforts. The summit goal was to work toward a better understanding of what dengue control could look like and the steps required to reach such a goal. The objectives of the meeting were to discuss the current global state of dengue, what dengue “control” might look like, and to discuss actionable pathways for achieving dengue control. Topics covered throughout the meeting included DENV immunity and pathogenesis, challenges in countermeasure development, innovative vector control strategies, dengue diagnostics, addressing challenges in science communication, and vaccine hesitancy. Several fundamental knowledge gaps were repeatedly highlighted by the summit attendees and were cited as critical barriers to the development, deployment, and evaluation of effective dengue countermeasures. These gaps include (1) the lack of a broadly applicable immunologic biomarker/ correlate of DENV immunity and (2) the lack of universally accepted/applicable metrics for quantifying dengue severity in the setting of countermeasure evaluations. In addition, the lack of clear and consistent international leadership in the global dengue control effort was cited as a barrier to widespread and synergistic research and countermeasure development/deployment activities. Despite these persistent roadblocks, summit attendees expressed optimism that holistic and multi-tiered approaches—incorporating optimal use of existing and nascent countermeasure technologies deployed in collaboration with local communities—could be effective in progressing toward dengue control.
UR - http://www.scopus.com/inward/record.url?scp=105004337111&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105004337111&partnerID=8YFLogxK
U2 - 10.1371/journal.pntd.0013028
DO - 10.1371/journal.pntd.0013028
M3 - Article
C2 - 40294026
AN - SCOPUS:105004337111
SN - 1935-2727
VL - 2025-April
JO - PLoS neglected tropical diseases
JF - PLoS neglected tropical diseases
M1 - e0013028
ER -